Vol 39, Issue 2

How can psychopharmacologists effectively (and safely) prescribe stimulants to patients with ADHD who may be using psychoactive substances?

The average patient with bipolar disorder struggles with sleep disorders. Here's how you can help.

Comorbidity: The concept is simple enough, but in practice, comorbidity drives complexity and presents the specters of diagnostic ambiguity and therapeutic unpredictability.

Catch up on all the latest in ADHD from the APSARD virtual 2022 Annual Meeting.

When therapists are terminally ill, should they err on the side of self-disclosure or silence?

As we aim to improve equity and diversity, a new study shines light on pay differences.

"...they’ve returned like songbirds, exhausted from flight but wild to swagger the songs they carry..."

Malingering is a common challenge for emergency department clinicians, particularly during the pandemic. Here are 3 cases of COVID-19–induced malingering.

Is sustained treatment with clozapine safe during the COVID-19 pandemic?

In this CME article, familiarize yourself with various pharmacokinetic, pharmacodynamic, and patient-specific factors to review to develop a successful cross-titration plan from one antipsychotic to another.

Despite uncertainties and stresses, the field of psychiatry is poised to have a better year.

Smart phones have the potential to be either a useful and highly constructive asset or a destructive and harmful diversion from life.

Does anxiety justify an exemption from vaccine mandates among health care workers?

Welcome to the psychedelic renaissance.